CLS delivered exceptional financial performance with net income nearly doubling to $832.5M and revenue growing 28.5% to $12.4B, demonstrating strong operational leverage and business momentum.
The dramatic 94.5% surge in net income significantly outpacing the 28.5% revenue growth indicates substantial margin expansion and operational efficiency gains. This exceptional performance, combined with strong cash generation and balance sheet growth, signals CLS has achieved meaningful scale advantages in its business model.
CLS demonstrated outstanding financial performance across all key metrics, with revenue growing 28.5% to $12.4B while net income nearly doubled to $832.5M, indicating powerful operational leverage. The company maintained strong liquidity with cash increasing 40.7% to $595.6M and operating cash flow growing 39.2% to $659.5M, while strategically investing in growth through a 51.5% increase in R&D spending. The proportional growth in current assets and liabilities alongside inventory expansion suggests controlled scaling to support the revenue surge, positioning CLS for continued growth momentum.
Net income grew 94.5% — bottom-line growth signals improving overall business health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
R&D investment increased 51.5% — signals commitment to future product development, though near-term margin impact.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Cash position surged 40.7% — strong cash generation or capital raise providing significant financial cushion.
Operating cash flow surged 39.2% — exceptional cash generation, highest quality earnings signal.
Current liabilities surged 30.4% — significant near-term obligations; verify ability to meet short-term debt.
Revenue growing 28.5% — solid top-line momentum, watch margins for quality of growth.
Current assets grew 25.7% — improving short-term liquidity or inventory/receivables build.
Inventory built 24.3% — monitor whether demand supports this build or if write-downs may follow.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →